Preoperative Vitamin B12 and Folic Acid on POCD in Elderly Non-cardiac Surgical Patients

NCT03485404 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-08-04

No results posted yet for this study

Summary

This study will recruit patients more than 65 years old eligible for non-cardiac surgery. Patients who participate will take either vitamin B12 and folic acid supplementation or placebo for 7 days before surgery. Neuropsychological test battery (NPB) will be tested before intervention and at discharge for determination of Post operative cognitive dysfunction (POCD). Another group of non-surgical elderly participants will also be tested for NPB to account for learning effect in POCD diagnosis. The hypothesis is that preoperative vitamin B12 supplementation will reduce the incidence of POCD in elderly patients undergoing non-cardiac surgery.

Conditions

  • Post Operative Cognitive Dysfunction

Interventions

DRUG

methylcobalamin

methylcobalamin tablets, 0.5mg/tablet, 3 tablets/day.

DRUG

Folic Acid

folic acid tablets, 5mg/tablet, 1 tablet/day

OTHER

Placebo for methylcobalamin

orange tablets that looks exactly like methylcobalamin

OTHER

Placebo for folic acid

yellow tablets that looks exactly like folic acid

PROCEDURE

non-cardiac surgery

patients elective for non-cardiac surgery will undergo scheduled surgery after 7 days of intervention

BEHAVIORAL

NPB test

participants will accept Mini-Mental State Examination (MMSE), Patient Health Questionnaire (PHQ-9), ADL, and NPB test before intervention, and NPB by discharge or similar time intermittent after the first assessment for non-surgical controls. Also ADL will be tested again through telephone interview at 3 months after discharge.

Sponsors & Collaborators

  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • Tang-Du Hospital

    collaborator OTHER
  • Shaanxi Provincial People's Hospital

    collaborator OTHER
  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    collaborator OTHER
  • Anhui Provincial Hospital

    collaborator OTHER_GOV
  • Shanghai 10th People's Hospital

    collaborator OTHER
  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Lize Xiong, M.D., Ph.D. · Xijing Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-10
Primary Completion
2021-07-29
Completion
2021-07-29

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03485404 on ClinicalTrials.gov